Did "Pharma Bro" Shkreli commit fraud? A jury now decides

The fate of "the most hated man in America" will soon be in a jury's hands. The federal securities fraud trial of former pharmaceutical CEO Martin Shkreli is moving toward the decision-making phase, with jurors potentially starting their deliberations Monday. On Friday, they heard closing arguments by prosecutors accusing Shkreli of looting his own drug company to pay back disgruntled investors in two failed hedge funds he ran.Assistant U.S. Attorney Alixandra Smith said in closing arguments at